|
|
|
|
LEADER |
03141nam a2200781Ia 4500 |
001 |
10.1002-jcla.23886 |
008 |
220427s2021 CNT 000 0 und d |
020 |
|
|
|a 08878013 (ISSN)
|
245 |
1 |
0 |
|a Serum osteoprotegerin level in hemodialysis patients using low-flux reused dialyzer in relation to atherosclerosis
|
260 |
|
0 |
|b John Wiley and Sons Inc
|c 2021
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1002/jcla.23886
|
520 |
3 |
|
|a Aims: To assess the relation of high serum OPG level and carotid atherosclerosis in maintenance hemodialysis (MHD) patients using low-flux reused dialyzer. Materials and Methods: We examined 209 MHD patients with and without carotid atherosclerosis (83 patients and 126 patients) to establish the relation between OPG and atherosclerosis. Results: The proportion of carotid atherosclerosis was 39.7%. The median serum OPG level was 45.3 pmol/L. Serum OPG had a good predicting value for atherosclerosis in MHD patients using low-flux reused dialyzer (AUC = 0.934, p < 0.001, cutoff value = 43.35 pmol/L, Se = 81.3%, Sp = 90.9%). Conclusions: In this study, serum OPG had a good predicting value for atherosclerosis in MHD patients using low-flux reused dialyzer. © 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
|
650 |
0 |
4 |
|a adult
|
650 |
0 |
4 |
|a Adult
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a atherosclerosis
|
650 |
0 |
4 |
|a atherosclerosis
|
650 |
0 |
4 |
|a Atherosclerosis
|
650 |
0 |
4 |
|a blood
|
650 |
0 |
4 |
|a carotid artery disease
|
650 |
0 |
4 |
|a Carotid Artery Diseases
|
650 |
0 |
4 |
|a carotid atherosclerosis
|
650 |
0 |
4 |
|a clinical trial
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a devices
|
650 |
0 |
4 |
|a diagnostic test accuracy study
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a Female
|
650 |
0 |
4 |
|a hemodialysis
|
650 |
0 |
4 |
|a hemodialysis
|
650 |
0 |
4 |
|a hemodialysis
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a Humans
|
650 |
0 |
4 |
|a Logistic Models
|
650 |
0 |
4 |
|a major clinical study
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a Male
|
650 |
0 |
4 |
|a middle aged
|
650 |
0 |
4 |
|a Middle Aged
|
650 |
0 |
4 |
|a multicenter study
|
650 |
0 |
4 |
|a osteoprotegerin
|
650 |
0 |
4 |
|a osteoprotegerin
|
650 |
0 |
4 |
|a Osteoprotegerin
|
650 |
0 |
4 |
|a predictive value
|
650 |
0 |
4 |
|a procedures
|
650 |
0 |
4 |
|a prognosis
|
650 |
0 |
4 |
|a protein blood level
|
650 |
0 |
4 |
|a receiver operating characteristic
|
650 |
0 |
4 |
|a Renal Dialysis
|
650 |
0 |
4 |
|a risk factor
|
650 |
0 |
4 |
|a sensitivity and specificity
|
650 |
0 |
4 |
|a serum osteoprotegerin
|
650 |
0 |
4 |
|a statistical model
|
650 |
0 |
4 |
|a TNFRSF11B protein, human
|
700 |
1 |
|
|a Bui Thi Thu, H.
|e author
|
700 |
1 |
|
|a Can Van, M.
|e author
|
700 |
1 |
|
|a Dao Bui Quy, Q.
|e author
|
700 |
1 |
|
|a Do Van, T.
|e author
|
700 |
1 |
|
|a Do, Q.
|e author
|
700 |
1 |
|
|a Le Thi Huong, L.
|e author
|
700 |
1 |
|
|a Le Viet, T.
|e author
|
700 |
1 |
|
|a Nguyen Cong, H.
|e author
|
700 |
1 |
|
|a Nguyen Duy, T.
|e author
|
700 |
1 |
|
|a Nguyen Minh, T.
|e author
|
700 |
1 |
|
|a Nguyen Trung, K.
|e author
|
700 |
1 |
|
|a Pham Quoc, T.
|e author
|
700 |
1 |
|
|a Tran Viet, T.
|e author
|
773 |
|
|
|t Journal of Clinical Laboratory Analysis
|